Covidien, a global supplier of healthcare products, has acquired technology assets from CardioDigital, a company specializing in the development of advanced signal processing techniques for patient monitoring.
Subscribe to our email newsletter
The technology, which will be used by Covidien’s respiratory and monitoring solutions business unit, reflects the company’s strong commitment to making investments in clinically relevant product innovations designed to improve patient outcomes.
CardioDigital’s innovative technology is expected to complement respiratory and monitoring solution’s Nellcor pulse oximetry platform.
Joe Almeida, president of medical devices at Covidien, said: “The acquisition of CardioDigital’s technology is an exciting opportunity for us to strengthen our patient monitoring business as we partner with our customers to improve outcomes.
“We believe that the technology will enable significant improvements in current patient monitoring techniques, resulting in enhanced patient care and safety.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.